ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
DiaMedica pulls off IPO to fund midphase stroke trial
fiercebiotech
December 28, 2018DiaMedica Therapeutics has wrapped up its IPO. The?offering?gives DiaMedica the cash to take its lead candidate through phase 2 trials in acute ischemic stroke (AIS) and chronic kidney disease (CKD).....
Pharma Sources Insight January 2025
